Showing posts with label identified. Show all posts
Showing posts with label identified. Show all posts

Wednesday, February 1, 2012

Transparency limits on transparent conducting oxides identified

 Researchers in the Computational Materials Group at the University of California, Santa Barbara (UCSB) have uncovered the fundamental limits on optical transparency in the class of materials known as transparent conducting oxides. Their discovery will support development of energy efficiency improvements for devices that depend on optoelectronic technology, such as light- emitting diodes and solar cells.


Transparent conducting oxides are used as transparent contacts in a wide range of optoelectronic devices, such as photovoltaic cells, light-emitting diodes (LEDs), and LCD touch screens. These materials are unique in that they can conduct electricity while being transparent to visible light. For optoelectronic devices to be able to emit or absorb light, it is important that the electrical contacts at the top of the device are optically transparent. Opaque metals and most transparent materials lack the balance between these two characteristics to be functional for use in such technology.


In a paper published in Applied Physics Letters, the UCSB researchers used cutting-edge calculation methods to investigate tin dioxide (SnO2), a widely-used conducting oxide.


Conducting oxides strike an ideal balance between transparency and conductivity because their wide band gaps prevent absorption of visible light by excitation of electrons across the gap, according to the researchers. At the same time, dopant atoms provide additional electrons in the conduction band that enable electrical conductivity. However, these free electrons can also absorb light by being excited to higher conduction-band states.


"Direct absorption of visible light cannot occur in these materials because the next available electron level is too high in energy. But we found that more complex absorption mechanisms, which also involve lattice vibrations, can be remarkably strong," says Hartwin Peelaers, a postdoctoral researcher and the lead author of the paper. The other authors are Emmanouil Kioupakis, now at the University of Michigan, and Chris Van de Walle, a professor in the UCSB Materials Department and head of the research group.


They found that tin dioxide only weakly absorbs visible light, thus letting most light pass through, so that it is still a useful transparent contact. In their study, the transparency of SnO2 declined when moving to other wavelength regions. Absorption was 5 times stronger for ultraviolet light and 20 times stronger for the infrared light used in telecommunications.


"Every bit of light that gets absorbed reduces the efficiency of a solar cell or LED," remarked Chris Van de Walle. "Understanding what causes the absorption is essential for engineering improved materials to be used in more efficient devices."


Story Source:



The above story is reprinted from materials provided by University of California - Santa Barbara.


Note: Materials may be edited for content and length. For further information, please contact the source cited above.


Journal Reference:

H. Peelaers, E. Kioupakis, C. G. Van de Walle. Fundamental limits on optical transparency of transparent conducting oxides: Free-carrier absorption in SnO2. Applied Physics Letters, 2012; 100 (1): 011914 DOI: 10.1063/1.3671162

Tuesday, January 24, 2012

Clearing a potential road block to bisabolane: Key enzyme structure identified

The JBEI research team, led by bioengineers Paul Adams and Jay Keasling, solved the protein crystal structure of an enzyme in the Grand fir (Abies grandis) that synthesizes bisabolene, the immediate terpene precursor to bisabolane. The performance of this enzyme – the Abies grandis ?-bisabolene synthase (AgBIS) – when engineered into microbes, has resulted in a bottleneck that hampers the conversion by the microbes of simple sugars into bisabolene.

“Our high resolution structure of AgBIS should make it possible to design changes in the enzyme that will enable microbes to make bisabolene faster,” says Adams, a leading authority on x-ray crystallography. “It should also enable us to engineer out inhibition effects that slow throughput, and perhaps also  engineer the enzyme to produce other kinds of fuels similar to bisabolane.”

Adams, who heads JBEI’s Technologies Division, is the corresponding author of a paper describing this work in the Cell Press journal Structure. The paper is titled “Structure of a Three-Domain Sesquiterpene Synthase: A Prospective Target for Advanced Biofuels Production.” Co-authoring it with Adams and Keasling were Ryan McAndrew, Pamela Peralta-Yahya, Andy DeGiovanni, Jose Pereira and Masood Hadi.

JBEI is one of three DOE Bioenergy Research Centers established by DOE’s Office of Science to advance the technology for the commercial production of advanced biofuels. It is a multi-institutional partnership led by the Lawrence Berkeley National Laboratory (Berkeley Lab) and headquartered in Emeryville, CA.

This past fall, JBEI researchers identified bisabolane as a potential new advanced biofuel that could replace D2 diesel, today’s standard fuel for diesel engines, with a clean, green, renewable alternative that’s produced in the United States. Using the tools of synthetic biology, the researchers engineered strains of bacteria and yeast to produce bisabolene from simple sugars, which was then hydrogenated into bisabolane. While showing much promise, the yields of bisabolene have to be improved for microbial-based production of bisabolane fuel to be commercially viable.

“The inefficient terpene synthase enzyme is one of the bottlenecks in the metabolic pathway used by the engineered microbes,” says Peralta-Yahya, a lead member of the earlier JBEI team as well as the current team. “Knowing the AgBIS crystal structure will guide us in engineering it for improved catalytic efficiency and stability, which should bring our bisabolene yields closer to economic competitiveness.”

Peralta-Yahya and her colleagues determined that the AgBIS enzyme consists of three helical domains, the first three-domain structure ever found in a synthase of sesquiterpenes – terpene compounds that contain 15 carbon atoms. The discovery of this unique structure holds importance on several fronts, as co-lead author of the Structure paper McAndrew explains.

“That we found the structure of AgBIS to be more similar to diterpene (two carbon terpene compounds) synthases not only provides us with insight into the function of these less well characterized enzymes, it also provides us with clues to the evolutionary heritage as the archetypal three-domain terpenoid synthases became two-domain sesquiterpene synthases in plants.

Furthering our knowledge of the structures and functions of terpenoid synthases may prove to have abundant practical applications aside from advanced biofuels because these enzymes produce a wide variety of specialized chemicals.”

Solving the three-dimensional of AgBIS was made possible by the protein crystallography capabilities of Berkeley Lab’s Advanced Light Source (ALS), a DOE Office of Science national user facility for synchrotron radiation, and the first of the world’s third generation light sources. For this work, the JBEI team used three of the five protein crystallography beamlines operated by the Berkeley Center for Structural Biology (BCSB) – beamlines 8.2.1, 8.2.2, and 5.0.3.

“We needed to use multiple beamlines because we collected data on several crystals – the protein by itself, and the protein with different inhibitors/cofactors,” says Adams, who headed the  BCSB from 2004 to 2011. “Also, the approach we used to solve the AgBIS required high flux tunable x-rays such as those provided at 8.2.1 and 8.2.2, which are superbend beamlines.”

Provided by Lawrence Berkeley National Laboratory (news : web)

Friday, December 16, 2011

Four new leads identified for anti-cancer drugs

Lead author Jason Smith undertook a comprehensive study that combined existing knowledge of an enzyme with a specifically tailored approach to identify novel inhibitors. The enzyme (indoleamine 2,3-dioxygenase) has generated excitement amongst researchers over the last decade due to its increasingly recognised role as a , particularly in cancer.

"Over the past ten years, scientists have learnt that compounds inhibiting this enzyme allow the immune system to attack . They have found that if you use these inhibitors alone, they slow tumour growth. Even more exciting is that in combination with chemotherapy, these inhibitors have the potential to destroy a tumour entirely," Smith explains.

After conducting virtual screening of a database of almost 60,000 compounds, Smith found 18 compounds that could hold potential as inhibitors of this enzyme. He then tested them in the lab and found four compounds with particularly exciting prospects.

Smith sees many strengths in the approach taken. "Computational chemistry means we don't have to spend years testing thousands of compounds in the lab. We can analyse all the potential and narrow them down in a matter of 6 month's preparation and virtual screening, instead of years. In fact, after all the preparation and groundwork, the screening itself takes around 100 hours."

This research was conducted as part of a collaboration between the Department of Chemistry and Biomolecular Sciences at Macquarie University and the School of Medical Sciences/Pharmacology, University of .

Although the leads are a way off from clinical trials, Smith and the team are excited about the future development of this research. Smith, a completing Master of Philosophy student, plans to continue study on these enzyme inhibitors as part of a Doctoral degree in 2012.

Provided by Macquarie University

Thursday, October 13, 2011

New advanced biofuel identified as an alternative to diesel fuel

 Researchers with the U.S Department of Energy (DOE)'s Joint BioEnergy Institute (JBEI) have identified a potential new advanced biofuel that could replace today's standard fuel for diesel engines but would be clean, green, renewable and produced in the United States.


Using the tools of synthetic biology, a JBEI research team engineered strains of two microbes, a bacteria and a yeast, to produce a precursor to bisabolane, a member of the terpene class of chemical compounds that are found in plants and used in fragrances and flavorings. Preliminary tests by the team showed that bisabolane's properties make it a promising biosynthetic alternative to Number 2 (D2) diesel fuel.


"This is the first report of bisabolane as a biosynthetic alternative to D2 diesel, and the first microbial overproduction of bisabolene in Escherichia coli and Saccharomyces cerevisiae," says Taek Soon Lee, who directs JBEI's metabolic engineering program and is a project scientist with Lawrence Berkeley National Laboratory (Berkeley Lab)'s Physical Biosciences Division. "This work is also a proof-of-principle for advanced biofuels research in that we've shown that we can design a biofuel target, evaluate this fuel target, and produce the fuel with microbes that we've engineered."


Lee is the corresponding author of a paper reporting this research in the journal Nature Communications. Co-authoring this paper were Pamela Peralta-Yahya, Mario Ouellet, Rossana Chan, Aindrila Mukhopadhyay and Jay Keasling.


The rising costs and growing dependence upon foreign sources of petroleum-based fuels, coupled with scientific fears over how the burning of these fuels impacts global climate, are driving the search for carbon-neutral renewable alternatives. Advanced biofuels -- liquid transportation fuels derived from the cellulosic biomass of perennial grasses and other non-food plants, as well as from agricultural waste -- are highly touted for their potential to replace gasoline, diesel and jet fuels. Unlike ethanol, which can only be used in limited amounts in gasoline engines and can't be used at all in diesel or jet engines, plus would corrode existing oil pipelines and tanks, advanced biofuels are drop-in fuels compatible with today's engines, and delivery and storage infrastructures.


"We desperately need drop-in, renewable biofuels that can directly replace petroleum-derived fuels, particularly for vehicles that cannot be electrified," says co-author Keasling, CEO of JBEI and a leading authority on advanced biofuels. "The technology we describe in our Nature Communications paper is a significant advance in that direction."


JBEI is one of three Bioenergy Research Centers established by the DOE's Office of Science in 2007. Researchers at JBEI are pursuing the fundamental science needed to make production of advanced biofuels cost-effective on a national scale. One of the avenues being explored is sesquiterpenes, terpene compounds that contain 15 carbon atoms (diesel fuel typically contains 10 to 24 carbon atoms).


"Sesquiterpenes have a high-energy content and physicochemical properties similar to diesel and jet fuels," Lee says. "Although plants are the natural source of terpene compounds, engineered microbial platforms would be the most convenient and cost-effective approach for large-scale production of advanced biofuels."


In earlier work, Lee and his group engineered a new mevalonate pathway (a metabolic reaction critical to biosynthesis) in both E. coli and S. cerevisiae that resulted in these two microorganisms over-producing a chemical compound called farnesyl diphosphate (FPP), which can be treated with enzymes to synthesize a desired terpene. In this latest work, Lee and his group used that mevalonate pathway to create bisabolene, which is a precursor to bisabolane.


"We proposed that the generality of the microbial FPP overproduction platforms would allow for the biosynthesis of sesquiterpenes," Lee says. "Through multiple rounds of large-scale preparation in shake flasks, we were able to prepare approximately 20 milliliters of biosynthetic bisabolene, which we then hydrogenated to produce bisabolane."


When they began this work, Lee and his colleagues did not know whether bisabolane could be used as a biofuel, but they targeted it on the basis of its chemical structure. Their first step was to perform fuel property tests on commercially available bisabolene, which comes as part of a mixture of compounds. Convinced they were onto something, the researchers then used biosynthesis to extract pure biosynthetic bisabolene from microbial cultures for hydrogenation into bisabolane. Subsequent fuel property tests on the bisabolane were again promising.


"Bisabolane has properties almost identical to D2 diesel but its branched and cyclic chemical structure gives it much lower freezing and cloud points, which should be advantageous for use as a fuel," Lee says. "Once we confirmed that bisabolane could be a good fuel, we designed a mevalonate pathway to produce the precursor, bisabolene. This was basically the same platform used to produce the anti-malarial drug artemisinin except that we introduced a terpene synthase and further engineered the pathway to improve the bisabolene yield both in E. coli and yeast."


Lee and his colleagues are now preparing to make gallons of bisabolane for tests in actual diesel engines, using the new fermentation facilities at Berkeley Lab's Advanced Biofuels Process Demonstration Unit. The ABPDU is a 15,000 square-foot state-of-the art facility, located in Emeryville, California, designed to help expedite the commercialization of advanced next-generation biofuels by providing industry-scale test beds for discoveries made in the laboratory.


"Once the complete fuel properties of hydrogenated biosynthetic bisabolene can be obtained, we'll be able to do an economic analysis that takes into consideration production variables such as the cost and type of feedstock, biomass depolymerization method, and the microbial yield of biofuel," Lee says. "We will also be able to estimate the impact of byproducts present in the hydrogenated commercial bisabolene, such as farnesane and aromatized bisabolene."


Ultimately, Lee and his colleagues would like to replace the chemical processing step of bisabolene hydrogenation with an alkene reductase enzyme engineered into the E. coli and yeast so that all of the chemistry is performed within the microbes.


"Enzymatic hydrogenation of this type of molecule is a very challenging project and will be a long term goal," Lee says. "Our near-term goal is to develop strains of E. coli and yeast for use in commercial-scale fermenters. Also, we will be investigating the use of sugars from biomass as a source of carbon for producing bisabolene."



Story Source:


The above story is reprinted (with editorial adaptations ) from materials provided by DOE/Lawrence Berkeley National Laboratory.

Journal Reference:

Pamela P. Peralta-Yahya, Mario Ouellet, Rossana Chan, Aindrila Mukhopadhyay, Jay D. Keasling, Taek Soon Lee. Identification and microbial production of a terpene-based advanced biofuel. Nature Communications, 2011; 2: 483 DOI: 10.1038/ncomms1494

Wednesday, March 16, 2011

Newly identified spider toxin may help uncover novel ways of treating pain and human diseases

Spider venom toxins are useful tools for exploring how ion channels operate in the body. These channels control the flow of ions across cell membranes, and are key components in a wide variety of biological processes and human diseases.

A newly identified toxin from the American Funnel Web spider acts on T-type and N-type , researchers from the University of California at Riverside have discovered. The toxin offers a new target for studying T-type channels, which play a role in , hypertension, epilepsy and pain.

"The blocking mechanism of the toxin is different from classical pore blocker toxins and voltage modifier toxins," says lead researcher Xiao Zhang, a postdoc at the Del Webb Center for Neuroscience in La Jolla, Calif. "It indicates a new toxin blocking mechanism on voltage-gated ion channels."

Zhang purified the toxin and created a recombinant version as part of his doctoral research at the University of California, Riverside. "If we can develop a calcium-channel blocker based on this , we could have a new way to identify how these channels work and develop drugs for treating pain and disease," says Zhang.

More information: The presentation, "A Spider Toxin and its Recombinant Isoform Block T-type and N-type Calcium Channels with High Affinity" by Xiao Zhang, Li Dai, and Michael E. Adams is at 1:00 p.m. on Wednesday, March 9, 2011 in the Baltimore Convention Center, Room 307. ABSTRACT: http://tinyurl.com/4nhp7m6

Provided by American Institute of Physics

Tuesday, March 15, 2011

Materials identified that may deliver more 'bounce'

ScienceDaily (Mar. 9, 2011) — Rutgers researchers have identified a class of high-strength metal alloys that show potential to make springs, sensors and switches smaller and more responsive.

The alloys could be used in springier blood vessel stents, sensitive microphones, powerful loudspeakers, and components that boost the performance of medical imaging equipment, security systems and clean-burning gasoline and diesel engines.

While these nanostructured metal alloys are not new -- they are used in turbine blades and other parts demanding strength under extreme conditions -- the Rutgers researchers are pioneers at investigating these new properties.

"We have been doing theoretical studies on these materials, and our computer modeling suggests they will be super-responsive," said Armen Khachaturyan, professor of Materials Science and Engineering in the Rutgers School of Engineering. He and postdoctoral researcher Weifeng Rao believe these materials can be a hundred times more responsive than today's materials in the same applications.

Writing in the March 11 issue of the journal Physical Review Letters, the researchers describe how this class of metals with embedded nanoparticles can be highly elastic, or "springy," and can convert electrical and magnetic energy into movement or vice-versa. Materials that exhibit these properties are known among scientists and engineers as "functional" materials.

One class of functional materials generates an electrical voltage when the material is bent or compressed. Conversely, when the material is exposed to an electric field, it will deform. Known as piezoelectric materials, they are used in ultrasound instruments; audio components such as microphones, speakers and even venerable record players; autofocus motors in some camera lenses; spray nozzles in inkjet printer cartridges; and several types of electronic components.

In another class of functional materials, changes in magnetic fields deform the material and vice-versa. These magnetorestrictive materials have been used in naval sonar systems, pumps, precision optical equipment, medical and industrial ultrasonic devices, and vibration and noise control systems.

The materials that Khachaturyan and Rao are investigating are technically known as "decomposed two-phase nanostructured alloys." They form by cooling metals that were exposed to high temperatures at which the nanosized particles of one crystal structure, or phase, are embedded into another type of phase. The resulting structure makes it possible to deform the metal under an applied stress while allowing the metal to snap back into place when the stress is removed.

These nanostructured alloys might be more effective than traditional metals in applications such blood vessel stents, which have to be flexible but can't lose their "springiness." In the piezoelectric and magnetorestrictive components, the alloy's potential to snap back into shape after deforming -- a property known as non-hysteresis -- could improve energy efficiency over traditional materials that require energy input to restore their original shapes.

In addition to potentially showing responses far greater than traditional materials, the new materials may be tunable; that is, they may exhibit smaller or larger shape changes and output force based on varying mechanical, electrical or magnetic input and the material processing.

The researchers hope to test the results of their computer simulations on actual metals in the near future.

The Rutgers team collaborated with Manfred Wittig, professor of Materials Science and Engineering at the University of Maryland. Their research was funded by the National Science Foundation and the U.S. Department of Energy.

Story Source:

The above story is reprinted (with editorial adaptations by ScienceDaily staff) from materials provided by Rutgers University.

Journal Reference:

Wei-Feng Rao, Manfred Wuttig, and Armen G. Khachaturyan. Giant Nonhysteretic Responses of Two-Phase Nanostructured Alloys. Phys. Rev. Lett., (in press)

Note: If no author is given, the source is cited instead.

Disclaimer: Views expressed in this article do not necessarily reflect those of ScienceDaily or its staff.